SCI
EW icon

Stableford Capital II’s Edwards Lifesciences EW Stock Holding History

Stableford Capital II’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,104
Closed -$533K – 136
2024
Q2 		$533K Buy
6,104
+159
+3% +$14.1K 0.21% 111
2024
Q1 		$568K Sell
5,945
-35
-0.6% -$2.94K 0.23% 104
2023
Q4 		$449K Buy
5,980
+155
+3% +$10.8K 0.19% 103
2023
Q3 		$366K Buy
5,825
+1
+0% +$80 0.17% 94
2023
Q2 		$456K Buy
+5,824
New +$506K 0.2% 90
2023
Q1 		– Sell
-4,786
Closed -$365K – 96
2022
Q4 		$365K Buy
+4,786
New +$369K 0.2% 94

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Stableford Capital II's EW Position: Q3 2024 in Review

Stableford Capital II sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 6,104 shares — an estimated $533K sold.

Stableford Capital II first reported a position in EW in Q4 2022 and held it in 6 quarters. The position peaked at $568K in Q1 2024. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Stableford Capital II reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Stableford Capital II sold 6,104 Edwards Lifesciences shares in Q3 2024, an estimated $533K.
  • Stableford Capital II first reported a position in Edwards Lifesciences in Q4 2022 and held it in 6 quarters.
  • Stableford Capital II's Edwards Lifesciences position peaked at $568K in Q1 2024.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Stableford Capital II's 13F filing for Q3 2024, filed 15 Oct 2024.